{"id":132120,"date":"2017-11-30T10:22:14","date_gmt":"2017-11-30T15:22:14","guid":{"rendered":"https:\/\/today.uconn.edu\/?post_type=school-college-post&#038;p=132120"},"modified":"2017-11-30T10:22:14","modified_gmt":"2017-11-30T15:22:14","slug":"leading-alzheimers-disease-expert-named-chair-neuroscience-uconn-med-school","status":"publish","type":"post","link":"https:\/\/today.uconn.edu\/2017\/11\/leading-alzheimers-disease-expert-named-chair-neuroscience-uconn-med-school\/","title":{"rendered":"Leading Alzheimer&#8217;s Disease Expert Named Chair of Neuroscience at UConn Med School"},"content":{"rendered":"<figure id=\"attachment_132121\" aria-describedby=\"caption-attachment-132121\" style=\"width: 200px\" class=\"wp-caption alignright\"><img decoding=\"async\" class=\"size-medium wp-image-132121 img-responsive lazyload\" data-src=\"https:\/\/today.uconn.edu\/wp-content\/uploads\/2017\/11\/DSC0003-200x300.jpg\" alt=\"This spring Riqiang Yan, Ph.D. will be the chair of neuroscience at UConn School of Medicine (Photo courtesy of Dr. Yan\/Lerner Research Institute).\" width=\"200\" height=\"300\" data-srcset=\"https:\/\/today.uconn.edu\/wp-content\/uploads\/2017\/11\/DSC0003-200x300.jpg 200w, https:\/\/today.uconn.edu\/wp-content\/uploads\/2017\/11\/DSC0003-768x1152.jpg 768w, https:\/\/today.uconn.edu\/wp-content\/uploads\/2017\/11\/DSC0003-682x1024.jpg 682w, https:\/\/today.uconn.edu\/wp-content\/uploads\/2017\/11\/DSC0003-280x420.jpg 280w, https:\/\/today.uconn.edu\/wp-content\/uploads\/2017\/11\/DSC0003.jpg 1898w\" data-sizes=\"(max-width: 200px) 100vw, 200px\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" style=\"--smush-placeholder-width: 200px; --smush-placeholder-aspect-ratio: 200\/300;\" \/><figcaption id=\"caption-attachment-132121\" class=\"wp-caption-text\">This spring Riqiang Yan, Ph.D. will be the chair of neuroscience at UConn School of Medicine (Photo courtesy of Dr. Yan\/Lerner Research Institute).<\/figcaption><\/figure>\n<p>Dr. Riqiang Yan will join <a href=\"https:\/\/medicine.uconn.edu\/\">UConn School of Medicine<\/a> as chair of the <a href=\"https:\/\/health.uconn.edu\/neuroscience\/\">Department of Neuroscience<\/a> this spring establishing the medical school\u2019s first research laboratory dedicated to studying and discovering potentially new treatments for Alzheimer\u2019s disease and other forms of neurodegenerative disease.<\/p>\n<p>Joining from the Cleveland Clinic, Yan is an internationally recognized neurodegenerative disease researcher specializing in identifying the biological culprits behind Alzheimer\u2019s disease. His five studies are funded by the NIH.<\/p>\n<p>Yan presently serves as the Cleveland Clinic\u2019s Morris R. and Ruth V. Graham Endowed Chair Professor and Vice Chair of Neurosciences and professor of molecular medicine at Case Western Reserve University. He received his Ph.D. from the University of Kentucky and completed a postdoctoral fellowship at The Rockefeller University.<\/p>\n<p>\u201cWe welcome Dr. Yan to UConn School of Medicine and Connecticut as he and his research programs are very highly respected by leaders and other scientists in the field,\u201d says Dr. Bruce T. Liang, dean of UConn School of Medicine.<\/p>\n<p>\u201cI am very excited to join UConn,\u201d says Yan. \u201cI see a new chapter ahead and an opportunity for UConn School of Medicine\u2019s Department of Neuroscience to truly shine brighter,\u201d says Yan.<\/p>\n<p>He adds: \u201cI look forward to mentoring our talented UConn neuroscientists and staff and watching their research, discoveries and list of increasing accomplishments grow even greater, along with more national recognition of their efforts.\u201d<\/p>\n<p>Along with the first dedicated Alzheimer\u2019s disease research lab at UConn, Yan\u2019s recruitment brings with it a host of research collaboration opportunities across the SOM and its Departments of Neurology, Neurosurgery, Psychiatry, Center on Aging, neurobiology and brain investigators at the University, as well as with the Jackson Laboratory for Genomic Medicine on UConn Health\u2019s campus.<\/p>\n<p>\u201cI look forward to working together to expand scientific and medical knowledge in the really important fields of neurodegenerative diseases,\u201d says Yan.<\/p>\n<figure id=\"attachment_132129\" aria-describedby=\"caption-attachment-132129\" style=\"width: 199px\" class=\"wp-caption alignright\"><img decoding=\"async\" class=\"size-medium wp-image-132129 img-responsive lazyload\" data-src=\"https:\/\/today.uconn.edu\/wp-content\/uploads\/2017\/11\/YAN040826-012-199x300.jpg\" alt=\"Yan and his lab are currently testing in mouse models the power and safety of several promising molecules to prevent or stop further \u03b2-amyloid growth (Image courtesy of Yan Lab).\" width=\"199\" height=\"300\" data-srcset=\"https:\/\/today.uconn.edu\/wp-content\/uploads\/2017\/11\/YAN040826-012-199x300.jpg 199w, https:\/\/today.uconn.edu\/wp-content\/uploads\/2017\/11\/YAN040826-012-768x1155.jpg 768w, https:\/\/today.uconn.edu\/wp-content\/uploads\/2017\/11\/YAN040826-012-681x1024.jpg 681w, https:\/\/today.uconn.edu\/wp-content\/uploads\/2017\/11\/YAN040826-012-279x420.jpg 279w, https:\/\/today.uconn.edu\/wp-content\/uploads\/2017\/11\/YAN040826-012.jpg 2000w\" data-sizes=\"(max-width: 199px) 100vw, 199px\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" style=\"--smush-placeholder-width: 199px; --smush-placeholder-aspect-ratio: 199\/300;\" \/><figcaption id=\"caption-attachment-132129\" class=\"wp-caption-text\">Yan and his lab are currently testing in mouse models the power and safety of several promising molecules to prevent or stop further \u03b2-amyloid growth (Image courtesy of Yan Lab).<\/figcaption><\/figure>\n<p>His research lab studies build upon his co-discovery of the BACE-1 protein, the very critical molecule that he revealed fuels the production of \u03b2-amyloid peptides, or plaque build-up, in the brains of Alzheimer\u2019s disease patients. Studies suggest that these peptides are toxic and lead to cognitive decline in patients with Alzheimer\u2019s.<\/p>\n<p>\u201cWe all have a hope that in 5 to 10 years with academia collaborating with pharmaceutical companies we will indeed have an effective drug to finally treat Alzheimer\u2019s disease,\u201d says Yan who reports there has not been an FDA-approved drug to try to treat the disease since 2002. \u201cIt\u2019s our big hope and we will be continuing to try hard at UConn to discover and test a new effective drug therapy to make this hope a reality to help those struggling with Alzheimer\u2019s and ease the burden of future patients and their families.\u201d<\/p>\n<p>Yan and his lab are currently testing in mouse models the power and safety of several promising molecules to target BACE-1 and inhibit its biological function to prevent or stop further \u03b2-amyloid growth.<\/p>\n<p>In addition, BACE-1 study explorations also are assisting Yan and his team in gaining greater insight into the important role reticulon 3 protein (RTN3) plays in the formation of dystrophic neurites in the brain which can lead to memory loss, dementia and Alzheimer\u2019s disease in the elderly. \u00a0The Yan lab is also exploring the treatment that aims to enhance neurogenesis in the adult and to replenish the loss of brain cells in AD and other neurodegenerative diseases.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>UConn School of Medicine has named Dr. Riqiang Yan of the Cleveland Clinic its new new chair of the Department of Neuroscience. Yan, a leading Alzheimer&#8217;s disease researcher, will join UConn in Spring 2018 to establish the medical school&#8217;s first laboratory dedicated to studying and finding new treatments for Alzheimer&#8217;s.<\/p>\n","protected":false},"author":98,"featured_media":132124,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_crdt_document":"","wds_primary_category":0,"wds_primary_series":0,"wds_primary_attribution":0,"footnotes":""},"categories":[1868],"tags":[],"magazine-issues":[],"coauthors":[1873],"class_list":["post-132120","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-meds"],"pp_statuses_selecting_workflow":false,"pp_workflow_action":"current","pp_status_selection":"publish","acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-05-29 16:58:32","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/posts\/132120","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/users\/98"}],"replies":[{"embeddable":true,"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/comments?post=132120"}],"version-history":[{"count":0,"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/posts\/132120\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/media\/132124"}],"wp:attachment":[{"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/media?parent=132120"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/categories?post=132120"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/tags?post=132120"},{"taxonomy":"magazine-issue","embeddable":true,"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/magazine-issues?post=132120"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/today.uconn.edu\/wp-rest\/wp\/v2\/coauthors?post=132120"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}